Release Date: 29/04/09 16:49 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 68.81KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%